Corrigendum to “Re-examining the characteristics of pediatric multiple sclerosis in the era of antibody-associated demyelinating syndromes” [Europ. J. Paediatr. Neurol. 41 (2022) 8–18 doi.org/10.1016/j.ejpn.2022.08.006, (S1090379822001246), (10.1016/j.ejpn.2022.08.006)]

dc.contributor.authorYılmaz, Ünsal
dc.contributor.authorGücüyener, Kıvılcım
dc.contributor.authorYavuz, Merve
dc.contributor.author˙ Ibrahim Oncel
dc.contributor.authorCanpolat, Mehmet
dc.contributor.authorSaltık, Sema
dc.contributor.authorÜnver, Olcay
dc.date.accessioned2025-03-20T09:44:55Z
dc.date.available2025-03-20T09:44:55Z
dc.date.issued2024
dc.departmentİzmir Bakırçay Üniversitesi
dc.description.abstractThe authors would like to apologise for any inconvenience caused. © 2024 European Paediatric Neurology Society
dc.identifier.doi10.1016/j.ejpn.2024.11.006
dc.identifier.issn1090-3798
dc.identifier.scopus2-s2.0-85210942515
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1016/j.ejpn.2024.11.006
dc.identifier.urihttps://hdl.handle.net/20.500.14034/2069
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherW.B. Saunders Ltd
dc.relation.ispartofEuropean Journal of Paediatric Neurology
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_Scopus_20250319
dc.subjectadult
dc.subjectadverse drug reaction
dc.subjectcontrolled study
dc.subjecterratum
dc.subjecthuman
dc.titleCorrigendum to “Re-examining the characteristics of pediatric multiple sclerosis in the era of antibody-associated demyelinating syndromes” [Europ. J. Paediatr. Neurol. 41 (2022) 8–18 doi.org/10.1016/j.ejpn.2022.08.006, (S1090379822001246), (10.1016/j.ejpn.2022.08.006)]
dc.typeErratum

Dosyalar